MEdia & events
Discover more about the Association by checking out our content. Stay up to date with our events, which bring together key stakeholders, to discuss important developments and issues for our industry.



Calendar
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
HAE Day :-)
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
PPTA International Plasma Protein Congress
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
Immune thrombocytopenia (ITP) Awareness Month
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
PPTA Business Forum
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
International Plasma Awareness Week
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
Alpha-1 Awareness Month
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
PPTA Plasma Protein Forum
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
Rare Disease Day
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
Bleeding Disorders Awareness Month
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
National Primary Immunodeficiency Awareness Month
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
World Hemophilia Day
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
HAE Day :-)
Media
Find out more about what we do and what’s important to our sector via our media resources. You can also check out our social media pages to keep up to date with current events.

Watch our interview with Prof. Richard Knight as he shares valuable perspectives on immunoglobulins

Patient Stories presented by PPTA

PPTA New Website and Brand Launch

The Brussels Times Hosts Event at the European Parliament

Take a tour of a plasma donation center in Frankfurt, Germany

The need for a policy change – Plasma donation
-%20Day%20One.jpg)
2022 International Plasma Protein Congress (IPPC): Day One
-%20Day%20One.jpg)
2022 International Plasma Protein Congress (IPPC): Day Two

Differentiating Plasma from Blood

U.S. Roundtable on Immunoglobulin Use

EU BTC revision – The socioeconomic benefits of plasma-derived medicines

Why is Donating Plasma Important?

Strengthening the EU Blood Directive for patients who need plasma-derived medicines

Meet Amber, a Teacher and Dedicated Plasma Donor

Europe needs to collect more plasma – Improving patient access to plasma-derived medicines

EU BTC revision – Facts about compensating plasma donors
.jpg)
Highlights from the April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)
.jpg)
April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)

“Introduction to the Global Journey of Plasma" webinar

Presentation of the 2020 Joachim Hilfenhaus Award

Presentation of the 2020 Robert W. Reilly Award

Highlights from the EP roundtable event “Ensuring Appropriate Patient Access to PDMPs”

Keynote Address – Admiral Brett Giroir, MD, U.S. HHS Assistant Secretary for Health

Experts on Coronavirus: The Virus, The Disease, Prevention and Treatment

Combating COVID-19 Industry Spotlight: Kedrion

Keynote Address – Stella Kyriakides, European Commissioner for Health and Food Safety

Plasma: An Overview

Patient Perspectives on COVID-19 and Access to Care

Welcome to the Global Plasma Summit

Combating COVID-19 Industry Spotlight: CoVIg-19 Plasma Alliance

Combating COVID-19 Industry Spotlight: Grifols

Plasma 101

Combating COVID-19 Industry Spotlight: Emergent

Spotlight on Plasma Part One: Together We Are Stronger

Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products

PPTA webinar on unique patient access challenges to plasma-derived medicinal products in COVID times link

Thank you, plasma donors!

From PPTA: "Thank you, plasma donors!"

Prof. Lieven Annemans Speaks about the Value of Plasma-Derived Therapies

The Power of Plasma Donation - Hungarian

The Power of Plasma Donation - Spanish

The Power of Plasma Donation - Czech

The Power of Plasma Donation - German
.jpg)
The Power of Plasma Donation Animation - English

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

Announcing PPTA’s New Global Chair

Announcing PPTA’s New Global Chair

Monkeypox Virus and Plasma Protein Therapies

Monkeypox Virus and Plasma Protein Therapies

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on Review of Donor Weight Loss Monitoring

PPTA Statement on Review of Donor Weight Loss Monitoring

Statement on Update on Safety of Albumin

Statement on Update on Safety of Albumin

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Human Parvovirus PARV4 and plasma protein therapies

Human Parvovirus PARV4 and plasma protein therapies

Ebola Virus and Plasma Protein Therapies

Ebola Virus and Plasma Protein Therapies

PPTA Statement on MSM Donor Policy

PPTA Statement on MSM Donor Policy

Zika Virus and Plasma Protein Therapies

Zika Virus and Plasma Protein Therapies
.jpg)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
.jpg)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.jpg)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.jpg)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies

A Note to U.S. Plasma Donors on the Spread of Coronavirus

A Note to U.S. Plasma Donors on the Spread of Coronavirus

PPTA Responds to The Guardian Article

PPTA Responds to The Guardian Article

PPTA Statement on FDA Guidance Documents

PPTA Statement on FDA Guidance Documents

PPTA Repeats Appeals for Plasma Donations

PPTA Repeats Appeals for Plasma Donations

New York and California recognize the importance of plasma donation

New York and California recognize the importance of plasma donation

Plasma Donors Should be Celebrated, not Denigrated

Plasma Donors Should be Celebrated, not Denigrated

PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

Yes, you can donate source plasma after getting the COVID vaccine

Yes, you can donate source plasma after getting the COVID vaccine

PPTA Statement on Immunoglobulin Use to Meet Clinical Need

PPTA Statement on Immunoglobulin Use to Meet Clinical Need

Human Plasma Donations Remain Important During COVID-19 Pandemic

Human Plasma Donations Remain Important During COVID-19 Pandemic

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

PPTA Responds to ProPublica Article

PPTA Responds to ProPublica Article

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

PPTA Disagrees with Ruling from Romanian Competition Council

PPTA Disagrees with Ruling from Romanian Competition Council

PPTA Leadership Update – Amy Efantis

PPTA Leadership Update – Amy Efantis

PPTA Statement on the Ukraine Crisis

PPTA Statement on the Ukraine Crisis

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Letter to Stakeholders re: European Data Program Update

PPTA Letter to Stakeholders re: European Data Program Update

PPTA Recognizes First Plasma Collection Centers Certified in Hungary

PPTA Recognizes First Plasma Collection Centers Certified in Hungary

PPTA Recognizes World Hemophilia Day 2014

PPTA Recognizes World Hemophilia Day 2014

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

Ensuring Access to Medicines for Patients

Ensuring Access to Medicines for Patients

PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Recognizes World Hemophilia Day–April 17, 2015

PPTA Recognizes World Hemophilia Day–April 17, 2015

Alabama Lowers Minimum Donation Age to 18

Alabama Lowers Minimum Donation Age to 18

PPTA Recognizes Essential Contributions of Plasma Donors

PPTA Recognizes Essential Contributions of Plasma Donors

PPTA Names Amy Efantis President & CEO

PPTA Names Amy Efantis President & CEO

Plasma-Derived Therapies Provide Significant Health Value Gain

Plasma-Derived Therapies Provide Significant Health Value Gain

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

EU Health Commissioner says plasma donation plays a vital role

EU Health Commissioner says plasma donation plays a vital role

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

Calling on EU Policymakers to Increase Plasma Donations

Calling on EU Policymakers to Increase Plasma Donations

Adoption of the EP report “EU Pharmaceutical Strategy”

Adoption of the EP report “EU Pharmaceutical Strategy”

Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University

Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation

Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation

Plasma is Life podcast series episode 2: U.S. Election 2020 Wrap-Up
PPTA Podcast
Learn more about why Plasma is Life through our podcasts, featuring a wide range of experts.

Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation

Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation

Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University
PPTA EVENTS
Stay up to date with our events, where you can network with our huge community and get more involved in our activities.


ADVOCACY TOOLKIT
This toolkit provides a one-stop resource for patient groups and association members interested in plasma protein therapies. You may use this information to frame your own advocacy efforts, educate your constituents, and strengthen your communications.
International Plasma Awareness Week toolkit (IPAW)
As a joint initiative of the PPTA and its member companies, IPAW aims to raise global awareness about source plasma collection and recognize the invaluable contribution of plasma donors. This toolkit was designed to enable partners, affiliated organizations and the media with resources to create and publicize events, such as IPAW.
Social media kit
PPTA’s social media channels seek to inform the public and engage with policymakers and patient stakeholder organizations as we advocate for access to plasma protein therapies. This tool kit offers captions and easy-to-post social media nuggets to support this cause on the daily basis.
Plasma advocacy material
This toolkit provides a one-stop resource for patients interested in plasma protein therapies. Here, you can learn about PPTA's work in both Europe and the U.S. and connect with other patient groups and consumer organizations.
Contact us
If you have any inquiries, get in touch with us by filling out our contact form.